Health In Tech, Inc. (NASDAQ:HIT) Short Interest Update

Health In Tech, Inc. (NASDAQ:HIT) was the target of a significant decline in short interest during the month of September. As of September 15th, there was short interest totaling 90,100 shares, a decline of 56.3% from the August 31st total of 206,400 shares. Based on an average trading volume of 1,000,000 shares, the short-interest ratio is currently 0.1 days. Currently, 1.2% of the company’s stock are sold short. Currently, 1.2% of the company’s stock are sold short. Based on an average trading volume of 1,000,000 shares, the short-interest ratio is currently 0.1 days.

Health In Tech Trading Down 4.0%

NASDAQ HIT opened at $3.37 on Friday. Health In Tech has a fifty-two week low of $0.51 and a fifty-two week high of $7.59. The stock has a 50-day simple moving average of $2.89 and a two-hundred day simple moving average of $1.51.

Health In Tech (NASDAQ:HIT) last announced its quarterly earnings results on Monday, July 21st. The company reported $0.01 earnings per share for the quarter, meeting the consensus estimate of $0.01. The company had revenue of $9.31 million for the quarter, compared to analysts’ expectations of $7.96 million.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Cubist Systematic Strategies LLC acquired a new position in shares of Health In Tech in the first quarter worth about $41,000. Arete Wealth Advisors LLC acquired a new position in Health In Tech in the 1st quarter worth about $47,000. Jane Street Group LLC purchased a new position in Health In Tech during the first quarter worth approximately $48,000. Finally, XTX Topco Ltd purchased a new stake in shares of Health In Tech in the first quarter valued at approximately $59,000.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Maxim Group raised shares of Health In Tech to a “strong-buy” rating and set a $2.50 target price on the stock in a research report on Thursday, June 26th. Wall Street Zen cut Health In Tech from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 9th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Health In Tech in a report on Saturday, September 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $2.50.

Health In Tech Company Profile

Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.